MBI-Guided Biopsy for Dense Breasts
Part of Cancer, Skin clinical trials.
This trial tests a newer imaging method, molecular breast imaging (MBI), to guide a breast biopsy. It may help people with dense breast tissue get a more accurate biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have dense breasts, as rated C or D on a standard mammogram (DBT).
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses molecular breast imaging (MBI) to help guide biopsies for women with breast abnormalities. It has two parts: one for women with past MBI findings that turned out to be benign, and another for women who need a biopsy now based on recent imaging.
This trial tests whether a type of MRI called Diffusion Weighted Imaging (DWI) can more accurately identify breast issues in women with dense breast tissue. If you have dense breasts and have already had a breast MRI with DWI, this study may help improve future diagnosis.
This trial tests a new Feminai device that maps breast tissue to find suspicious lumps. If you're coming for a routine mammogram or a biopsy, this could help improve detection.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This study is testing whether adding an MRI to your regular mammogram can help find any new breast cancers earlier. It is for women who have had breast cancer before and still have dense breast tissue, making mammograms harder to read.
This study looks at breast cancer risk by analyzing what is seen in dense breast tissue during a screening ultrasound. It may help improve how doctors evaluate risk in people with very dense breasts.
Hear when a new Breast Cancer Detection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.